Search for: "Pamela L. Fisher" Results 1 - 20 of 21
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2019, 4:16 am by Andrew Lavoott Bluestone
On Lam v Arnold Montag Architect  2019 NY Slip Op 30712(U)  March 13, 2019 Supreme Court, Kings County Docket Number: 522413/2017 Judge: Pamela L. [read post]
11 May 2010, 11:28 am by Minnesota Law Review
Fisher, III, The Implications for Law of User Innovation, 94 Minn. [read post]
29 Jul 2020, 6:04 am
Posted by Pamela Marcogliese, Michael Levitt, and Amy Fisher, Freshfields Bruckhaus Deringer LLP, on Wednesday, July 29, 2020 Editor's Note: Pamela L. [read post]
8 Oct 2010, 6:00 am
Eisgruber, Provost, Princeton University; former clerk for Justice John Paul Stevens Jeffrey L. [read post]
6 Oct 2010, 5:35 am by Lawrence Solum
Eisgruber, Princeton University; former clerk for Justice John Paul StevensProfessor Jeffrey L. [read post]
15 Sep 2010, 11:13 am by Anna Christensen
Fisher of Stanford Law School, and Elizabeth B. [read post]
12 Aug 2010, 11:56 am by Chuck Ramsay
Leoni, Joe Scott, John Casanova, Jennifer Leunig, John Scott, Mike Cecchini, Pamela Leviton, James H. [read post]
31 Jul 2020, 6:02 am
Securities and Exchange Commission, on Friday, July 24, 2020 Tags: Boards of Directors, Institutional Investors, Proxy plumbing, Proxy voting, SEC, SEC rulemaking, Securities regulation, Shareholder voting Statement by Commissioner Roisman at Open Meeting to Adopt Amendments to the Proxy Solicitation Rules Posted by Elad L. [read post]
5 Mar 2007, 11:57 am
Fidell, President, National Institute of Military Justice; Partner, Feldesman Tucker Leifer Fidell LLP Louis Fisher, Specialist in Constitutional Law, Law Library, Library of Congress Melvin A. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]